Chemokine receptor polymorphism and risk of acute rejection in human renal transplantation

Journal of the American Society of Nephrology

Volumn 13, Issue 3, 2002, Pages 754-758

  Abdi, Reza ^a   Bich Huong, Tran Thi ^a   Sahagun Ruiz, Alfredo ^a   Murphy, Philip M ^a   Brenner, Barry M ^a   Milford, Edgar L ^a   McDermott, David H ^a  

^a NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOKINE RECEPTOR; CHEMOKINE RECEPTOR CCR2; CHEMOKINE RECEPTOR CCR5; CHEMOKINE RECEPTOR CX3CR1; UNCLASSIFIED DRUG;

ADULT; ALLELE; ARTICLE; DNA POLYMORPHISM; FEMALE; GENETIC VARIABILITY; GENOTYPE; HOMOZYGOSITY; HUMAN; INCIDENCE; KIDNEY GRAFT REJECTION; KIDNEY TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; OUTCOMES RESEARCH; PRIORITY JOURNAL; RISK FACTOR;

EID: 0036191887     PISSN: 10466673     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Chronic renal allograft loss
2. Cellular and molecular parameters in human allograft rejection
3. Renal transplantation
4. Antigen-independent determinants of cadaveric kidney transplant failure
5. Chemokines and their receptors in allograft rejection
6. International Union of Pharmacology. XXII. Nomenclature for chemokine receptors
7. Expression of chemokines and chemokine receptors during human renal transplant rejection
8. Renal allograft rejection: Beta-chemokine involvement in the development of tubulitis
9. Monocyte chemotactic peptide- 1 expression and monocyte infiltration in acute renal transplant rejection
10. Met-RANTES reduces vascular and tubular damage during acute renal transplant rejection: Blocking monocyte arrest and recruitment
11. A role for fractalkine and its receptor (CX3CR1) in cardiac allograft rejection
12. Genetic restriction of HIV-1 infection and progression to AIDS by a deletion allele of the CKR5 structural gene. Hemophilia Growth and Development Study, Multicenter AIDS Cohort Study, Multicenter Hemophilia Cohort Study. San Francisco City Cohort, ALIVE study
13. Inherited resistance to HIV-1 conferred by an inactivating mutation in CC chemokine receptor 5: Studies in populations with contrasting clinical phenotypes, defined racial background, and quantified risk
14. CCR5 promoter polymorphism and HIV-1 disease progression. Multicenter AIDS Cohort Study (MACS)
15. Contrasting genetic influence of CCR2 and CCR5 variants on HIV-1 infection and disease progression. Hemophilia Growth and Development Study (HGDS), Multicenter AIDS Cohort Study (MACS), Multicenter Hemophilia Cohort Study (MHCS), San Francisco City Cohort (SFCC). ALIVE study
16. Rapid progression to AIDS in HIV+ individuals with a structural variant of the chemokine receptor CX 3CRI
17. Genetic polymorphism in CX 3CR1 and risk of HIV disease
18. Chemokine receptors as HIV-1 coreceptors: Roles in viral entry, tropism, and disease
19. Association between polymorphism in the chemokine receptor CX 3CR1 and coronary vascular endothelial dysfunction and atherosclerosis
20. Genetic acceleration of AIDS progression by a promoter variant of CCR 5
21. Influence of nucleotide polymorphisms in the CCR 2 gene and the CCR5 promoter on the expression of cell surface CCR5 and CXCR4
22. CCR5 levels and expression pattern correlate with infectability by macrophage-tropic HIV- 1, in vitro
23. Resistance to experimental autoimmune encephalomyelitis in mice lacking the CC chemokine receptor (CCR) 2
24. CC chemokine receptor 2 is critical for induction of experimental autoimmune encephalomyelitis
25. CC chemokine receptor 5 and renal-transplant survival